QDEL.NASDAQQuidelortho CORP

SCHEDULE: Neuberger Berman Discloses Stake in QuidelOrtho Corp

Sentiment:

Beneficial Ownership Filing


Neuberger Berman Group LLC and its affiliates have reported beneficial ownership of 5.2% of QuidelOrtho Corp's common stock as of June 30, 2026.

Summary

  • Neuberger Berman Group LLC and its affiliated entities, including Neuberger Berman Investment Advisers LLC, have filed a Schedule 13G indicating beneficial ownership of QuidelOrtho Corp common stock.
  • As of June 30, 2026, the aggregate amount beneficially owned is 3,534,619 shares, representing 5.2% of the class.
  • Neuberger Berman Investment Advisers LLC individually holds shared voting power over 2,390,070 shares and shared disposition power over 3,202,589 shares, totaling 4.7% of the class.
  • The filing clarifies that while Neuberger Berman entities may be deemed beneficial owners due to shared voting or disposition power in their fiduciary capacities, they disclaim beneficial ownership beyond their economic interest.
  • The securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It's a standard disclosure of beneficial ownership by an institutional investor, indicating a significant stake but without immediate implications for control or strategy.

Positives

  • Neuberger Berman's investment indicates confidence in QuidelOrtho Corp's business prospects.
  • The filing is a routine disclosure, suggesting no immediate change in control or activist intent.

Negatives

  • The filing does not contain specific financial performance data or forward-looking guidance from QuidelOrtho Corp itself, as it is a disclosure by a beneficial owner.
  • The aggregate beneficial ownership is spread across various Neuberger Berman entities and client accounts, with no single entity holding sole voting or dispositive power over a majority of the reported shares.

Risks

  • Potential for future changes in investment strategy by Neuberger Berman could impact QuidelOrtho Corp's stock.
  • The disclaimer of beneficial ownership and economic interest by Neuberger Berman entities suggests a passive investment role, but this could change.

Future Outlook

The filing does not contain forward-looking statements or guidance from QuidelOrtho Corp. It is a disclosure of beneficial ownership by Neuberger Berman Group LLC and its affiliates.

Management Comments

  • Neuberger Berman Group LLC and its affiliates may be deemed to beneficially own the securities covered by this report in their various fiduciary capacities by virtue of the provisions of Exchange Act Rule 13d-3.
  • This report is not an admission that any of these entities are the beneficial owner of the securities covered by this report and each of Neuberger Berman Group LLC, Neuberger Berman Investment Advisers Holdings LLC, Neuberger Trust Holdings LLC, Neuberger Berman Trust Co N.A., Neuberger Berman Asia Ltd., Neuberger Berman Canada ULC, Neuberger Berman Trust Co of Delaware N.A. and Neuberger Berman Investment Advisers LLC and certain affiliated persons disclaim beneficial ownership of the securities covered by this statement pursuant to Exchange Act Rule 13d-4.
  • Neuberger Berman Group LLC or its affiliated persons do not, however, have any economic interest in the securities of those clients. The clients have the sole right to receive and the power to direct the receipt of dividends from or proceeds from the sale of such securities.
  • By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. This filing indicates Neuberger Berman's position as a substantial, though passive, shareholder in the diagnostics and healthcare sector, a field where QuidelOrtho Corp operates.

Stakeholder Impact

  • Shareholders: The filing confirms Neuberger Berman as a significant institutional holder, which can be viewed positively by the market. However, the passive nature of the filing suggests no immediate impact on share price or corporate strategy.
  • Employees: No direct impact mentioned.
  • Customers: No direct impact mentioned.
  • Suppliers: No direct impact mentioned.
  • Creditors: No direct impact mentioned.

Next Steps

  • Continued monitoring of Neuberger Berman's stake and any potential changes in their investment strategy.
  • QuidelOrtho Corp will continue its business operations as disclosed in its other SEC filings.

Key Dates

DateDescription
1934-01-01T00:00:00.000ZSecurities Exchange Act of 1934
1940-01-01T00:00:00.000ZInvestment Company Act of 1940
1998-01-12T00:00:00.000ZSEC Release No. 34-39538 regarding information barriers
2026-06-30T00:00:00.000ZDate of Event Which Requires Filing of this Statement
2026-07-08T00:00:00.000ZSignature Date for Neuberger Berman Group LLC and Neuberger Berman Investment Advisers LLC

Keywords

QuidelOrtho Corp, Schedule 13G, Neuberger Berman Group LLC, Neuberger Berman Investment Advisers LLC, Beneficial Ownership, Common Stock, SEC Filing, Investment Management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.